Clinical trial registry record

An Open-Label Pilot Study of Qualia Senolytic Supplementation for the Attenuation of Systemic Inflammatory Cytokines

A registered study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Not Yet Recruiting.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated May 1, 2025.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT06953518
Last registry update
May 1, 2025
Status
Not Yet Recruiting
Phase
Phase not reported
Sponsor
Qualia Life Sciences
Enrollment
40
Countries
United States
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
NA · SINGLE GROUP · BASIC SCIENCE · NONE
Evidence population
Human clinical study registration
Participants
40
Population
ALL · 45 Years to 79 Years
Duration
2025-05-12 to 2025-05-18
Intervention
Qualia Senolytic
Comparator
Qualia Senolytic
Outcomes measured
Olink Target 48 Cytokine panel - TNF, IL1B, CXCL8, VEGFA — 1 week; Remaining biomarkers in the Olink Target 48 Cytokine panel — 1 week; 36-Item Short Form Health Survey (SF-36) — 1 week; Frailty Index for Elders (FIFE) — 1 week; Depression Anxiety Stress Scale-21 (DASS-21) — 1 week; Aging Male/Female Symptom scale — 1 week; Side effect profile as measured by a custom Safety and Tolerability survey — 1 week
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Senolytics · 100%Title contains controlled term: senolytic. Source terminology contains: senolytic. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.

senolytics
Open primary sourceExport JSON